BCG Vaccine Market Size, Global Analytical Overview, Key Players, Regional Demand, Trends and Forecast 2022 to 2030

The Global BCG Vaccine Market size is estimated to be USD 48.9 million in 2019 and is predicted to reach USD 77.7 million by 2030 with a CAGR of 4.3% from 2020-2030.

BCG vaccine is also known as Bacillus Calmette?Guérin vaccine which is used for immunization of infants against tuberculosis which helps in the prevention of tuberculosis in the infants later in their life. This vaccine also prevents some other infections such as Buruli ulcer infection and others. In some cases it is also used for the treatment of bladder cancer.

Access Full Description of this report at:-

https://www.nextmsc.com/report/bcg-vaccine-market

Top Companies: Sanofi Pasteur, Merck & Co., Inc., China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Japan BCG Laboratory, InterVax Ltd., Serum Institute of India Pvt. Ltd., Statens Serum Institut and others.

Market Dynamics and Trends

There have been modernization and improvement in the healthcare infrastructure with various technological advancements over the forecast period. Moreover, increase in the prevalence of tuberculosis in developing economies is expected to further drive the market growth.

On the other hand increase in public awareness about immunization and government initiative to focus on immunization programs are also expected to augment the market growth. However, side effects and shortage of BCG vaccines are expected to hamper the growth of BCG vaccine market. Moreover, increase in research and development activities coupled with increase in investment in the developing countries and increase in CSR activities by various pharmaceutical companies to provide free vaccinations are further expected to create ample opportunities in the BCG vaccine market.

Request sample copy of this report at:-

https://www.nextmsc.com/bcg-vaccine-market/request-sample

Market Segmentations and Scope of the Study:

The global BCG vaccine market share is analyzed on the basis of drug type, usage, end user, and geography. On the basis of drug type, the market is segmented into Immune BCG and Therapy BCG. On the basis of usage, the market is divided into Tuberculosis and Bladder Cancer. Based on end user, the market is fragmented into Pediatrics and Adults. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America denotes a higher adoption of the BCG vaccine and is anticipated hold the highest market share during the forecast period. This is attributable to the factors including presence of well-established healthcare amenities, increased public awareness about immunization and technological advancements.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to increasing accessibility to healthcare facilities in the region, increasing medical facilities, government initiatives to increase immunization coupled with increased prevalence of tuberculosis.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.